Literature DB >> 34484661

Changes of renal transporters in the kinetic process of VCM-induced nephrotoxicity in mice.

Hongjing Li1, Qiaoling Yang1, Mingzhu Gui1, Lili Ding2, Li Yang2, Huajun Sun1, Zhiling Li1.   

Abstract

Renal transporters involved in tubular excretion pathway are considered to be the key concern in drug evaluations in nephrotoxicity. However, the relationship between the alternation of renal transporters and the kinetic process of vancomycin (VCM)-induced nephrotoxicity has not been fully elucidated. The present study investigated the alteration of renal transporters expression in the kinetic process of VCM-induced nephrotoxicity in mice. C57BL/6 mice were administrated with normal saline or VCM for 7 days. Biochemical and pathological analyses were conducted to investigate the nephrotoxicity induced by VCM administration. Renal oxidative status, plasma, and kidney content of VCM were monitored. Quantitative real-time polymerase chain reaction and immunohistochemistry analyses were performed to analyze the expression of renal transporters. Finally, our data showed that the exposure of VCM (400 mg/kg) caused a slight nephrotoxicity in mice, whereas exposure of VCM (600 mg/kg) resulted in the severe nephrotoxicity in mice as evidenced by biochemical parameters and renal morphological changes. In addition, the accumulation of VCM in kidney is higher than plasma. Interestingly, VCM (600 mg/kg, body weight) resulted in the induction of Oct2-Mate1 and Oat1/3-Mrp2/Mrp4/Bcrp pathways. However, VCM (400 mg/kg, body weight) caused the induction of Oct2-Mate1/Mate2 and Oat1/3-Mrp4/Bcrp pathways. The changes of renal transporters in association with the kinetic process of VCM-induced nephrotoxicity may exert important practical implications for its optimal use in clinic. © Crown copyright 2021.

Entities:  

Keywords:  nephrotoxicity; oxidative status; renal transporters; vancomycin

Year:  2021        PMID: 34484661      PMCID: PMC8403606          DOI: 10.1093/toxres/tfab048

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   2.680


  35 in total

1.  In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.

Authors:  Faruk Oktem; Meltem Koyuncu Arslan; Fehmi Ozguner; Ozden Candir; H Ramazan Yilmaz; Metin Ciris; Efkan Uz
Journal:  Toxicology       Date:  2005-08-19       Impact factor: 4.221

2.  High-throughput determination of vancomycin in human plasma by a cost-effective system of two-dimensional liquid chromatography.

Authors:  Yanghao Sheng; Boting Zhou
Journal:  J Chromatogr A       Date:  2017-02-27       Impact factor: 4.759

3.  Aloe-emodin induces hepatotoxicity by the inhibition of multidrug resistance protein 2.

Authors:  De-Ming Liu; Dong Yang; Chun-Yan Zhou; Jia-Si Wu; Guo-Lin Zhang; Ping Wang; Fei Wang; Xian-Li Meng
Journal:  Phytomedicine       Date:  2019-12-09       Impact factor: 5.340

4.  Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.

Authors:  Frank Kloprogge; Louise F Hill; John Booth; Nigel Klein; Adam D Irwin; Garth Dixon; Joseph F Standing
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

5.  Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110.

Authors:  Yan Zhang; Mark S Warren; Xuexiang Zhang; Sharon Diamond; Bill Williams; Naresh Punwani; Jane Huang; Yong Huang; Swamy Yeleswaram
Journal:  Drug Metab Dispos       Date:  2015-01-20       Impact factor: 3.922

6.  Vancomycin-Associated Nephrotoxicity: The Obesity Factor.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Zachary C Dietch; Rhett N Willis; Puja M Shah; Sara A Hennessy; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-09-01       Impact factor: 2.150

7.  Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects.

Authors:  Marie-Laure Boof; Atef Halabi; Mike Ufer; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2019-12-13       Impact factor: 2.953

8.  Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney.

Authors:  Yumiko Urakami; Naoko Kimura; Masahiro Okuda; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 9.  Renal vulnerability to drug toxicity.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-11       Impact factor: 8.237

10.  Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model.

Authors:  Dorina Diekjürgen; David W Grainger
Journal:  Pflugers Arch       Date:  2018-05-09       Impact factor: 3.657

View more
  1 in total

Review 1.  Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application.

Authors:  Wei-Chih Kan; Yi-Chih Chen; Vin-Cent Wu; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.